Filana Therapeutics (FLNA) Notes Payables (2024)
Filana Therapeutics (FLNA) posted quarterly Notes Payables of $65.4 million for Q1 2024.
Filana Therapeutics (FLNA) Notes Payables (2024) Analysis & Trends
Filana Therapeutics' Notes Payables history runs 1 years deep, the most recent figure standing at $65.4 million for Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | Filana Therapeutics | 45.71 Mn | 45.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 65.37 Mn |